
### [MONDO:0019350](http://purl.obolibrary.org/obo/MONDO_0019350)
**Label:** hereditary spherocytosis

**Subclasses:** [MONDO:0000913](http://purl.obolibrary.org/obo/MONDO_0000913) (hereditary spherocytosis type 2), [MONDO:0012981](http://purl.obolibrary.org/obo/MONDO_0012981) (hereditary spherocytosis type 4), [MONDO:0010053](http://purl.obolibrary.org/obo/MONDO_0010053) (hereditary spherocytosis type 3), [MONDO:0012985](http://purl.obolibrary.org/obo/MONDO_0012985) (hereditary spherocytosis type 5), [MONDO:0008447](http://purl.obolibrary.org/obo/MONDO_0008447) (hereditary spherocytosis type 1), 

**Corr. equiv. classes:** [OMIM:612653](http://purl.obolibrary.org/obo/OMIM_612653), [OMIM:616649](http://purl.obolibrary.org/obo/OMIM_616649), [OMIM:182900](http://purl.obolibrary.org/obo/OMIM_182900), [OMIM:270970](http://purl.obolibrary.org/obo/OMIM_270970), [OMIM:612690](http://purl.obolibrary.org/obo/OMIM_612690), 

**Class expressions from DL-Learner:**

- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0004444](http://purl.obolibrary.org/obo/HP_0004444) (Spherocytosis) 95.64%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0004444](http://purl.obolibrary.org/obo/HP_0004444) (Spherocytosis) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) 95.64%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0001903](http://purl.obolibrary.org/obo/HP_0001903) (Anemia) and [HP:0004444](http://purl.obolibrary.org/obo/HP_0004444) (Spherocytosis) 95.64%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0001878](http://purl.obolibrary.org/obo/HP_0001878) (Hemolytic anemia) and [HP:0004444](http://purl.obolibrary.org/obo/HP_0004444) (Spherocytosis) 95.64%
- [HP:0004444](http://purl.obolibrary.org/obo/HP_0004444) (Spherocytosis) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) 92.26%
- [HP:0001903](http://purl.obolibrary.org/obo/HP_0001903) (Anemia) and [HP:0004444](http://purl.obolibrary.org/obo/HP_0004444) (Spherocytosis) 92.26%
- [HP:0004444](http://purl.obolibrary.org/obo/HP_0004444) (Spherocytosis) 89.53%
- [HP:0004444](http://purl.obolibrary.org/obo/HP_0004444) (Spherocytosis) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) 80.00%
- [HP:0004312](http://purl.obolibrary.org/obo/HP_0004312) (Abnormality of reticulocytes) and [HP:0004444](http://purl.obolibrary.org/obo/HP_0004444) (Spherocytosis) 80.00%
- [HP:0004297](http://purl.obolibrary.org/obo/HP_0004297) (Abnormality of the biliary system) and [HP:0004444](http://purl.obolibrary.org/obo/HP_0004444) (Spherocytosis) 80.00%
- [HP:0002904](http://purl.obolibrary.org/obo/HP_0002904) (Hyperbilirubinemia) and [HP:0004444](http://purl.obolibrary.org/obo/HP_0004444) (Spherocytosis) 80.00%
- [HP:0001923](http://purl.obolibrary.org/obo/HP_0001923) (Reticulocytosis) and [HP:0004444](http://purl.obolibrary.org/obo/HP_0004444) (Spherocytosis) 80.00%
- [HP:0001396](http://purl.obolibrary.org/obo/HP_0001396) (Cholestasis) and [HP:0004444](http://purl.obolibrary.org/obo/HP_0004444) (Spherocytosis) 80.00%
- [HP:0001392](http://purl.obolibrary.org/obo/HP_0001392) (Abnormality of the liver) and [HP:0004444](http://purl.obolibrary.org/obo/HP_0004444) (Spherocytosis) 80.00%
- [HP:0001005](http://purl.obolibrary.org/obo/HP_0001005) (Dermatological manifestations of systemic disorders) and [HP:0004444](http://purl.obolibrary.org/obo/HP_0004444) (Spherocytosis) 80.00%


